PDC*line Pharma is hiring a Senior Production Supervisor / Production Technician in Belgium. Are you interested to join an international dynamic team in the biotech cancer vaccine space?

Be part of...

Jobs

Very are delighted to announce that our CEO Eric Halioua will chair a panel April 28th at the 5th Neoantigen Summit Europe organized by Hanso Wade in Amsterdam, Netherlands from April 26th to April...

Events

We are delighted to announce of the publication by our CSO Joël Plumas of a new review article in scientific journal Current Opinion in Oncology and intitled "Harnessing dendritic cells for innovative...

In the press

PDC*line Pharma raises €17.5 million ($20,3M) in Series B2 financing round

New funding includes €11.8M in equity and €5.7M in grants. It completes the €20M B1 round of financing announced in January...

Press releases

B2 cohort (high dose added to anti-PD-1) of the PDC-LUNG-101 trial with PDC*lung01 therapeutic cancer vaccine candidate for non-small cell lung cancer has been opened and first patients were dosed

 ...

Press releases

B2 cohort (high dose added to anti-PD-1) of the PDC-LUNG-101 trial with PDC*lung01 therapeutic cancer vaccine candidate for non-small cell lung cancer has been opened and first patients were dosed

 ...

Press releases

It has been a pleasure and an honor for our CEO Eric Halioua to participate Friday October 8th as a speaker at the EU-Korea Global Vaccine partnership roundtable with Mr Han-koo Yeo, Minister for...

Events

Available now for replay, the interview of PDC*line Pharma 's President & CEO Eric Halioua by journalist of the program « Itinéraires santé » in the TV studio of the French Media group Le Figaro

In...

In the press

In replay, the intervention of our CEO Eric Halioua and one of our investors Marc Foidart of the Noshaq fund on Monday May 17th at the "Success stories" program dedicated to the Biotechnology on the...

In the press